• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[吩噻嗪所致心肌病患者的心电图特点]

[Peculiarities of ECG in patients with phenothiazine-induced cardiomyopathy].

作者信息

Volkov V P

出版信息

Klin Med (Mosk). 2011;89(4):27-30.

PMID:21932558
Abstract

Ten most common and clinically significant pathological changes of ECG in schizophrenic patients with and without phenothiazine-induced cardiomyopathy (PCMP) at different stages of neuroleptic therapy are considered. A total of 46 men and 10 women were available for observation. The results of ECG studies in schizophrenics with PCMP and psychically healthy patients with DCMP were virtually identical. Dynamics of certain characteristics was shown to be of value for early diagnostics of phenothiazine cardiotoxic side-effects. These data confirm the advisability of regarding PCMP as a separate nosological entity in the group of seconfary cardiomyopathies.

摘要

研究了接受抗精神病药物治疗不同阶段的精神分裂症患者,有或无吩噻嗪所致心肌病(PCMP)的情况下,心电图最常见且具有临床意义的十种病理变化。共有46名男性和10名女性可供观察。患有PCMP的精神分裂症患者与患有药物性心肌病(DCMP)的心理健康患者的心电图研究结果基本相同。某些特征的动态变化对于吩噻嗪心脏毒性副作用的早期诊断具有价值。这些数据证实了将PCMP视为继发性心肌病组中一个独立病种的合理性。

相似文献

1
[Peculiarities of ECG in patients with phenothiazine-induced cardiomyopathy].[吩噻嗪所致心肌病患者的心电图特点]
Klin Med (Mosk). 2011;89(4):27-30.
2
[Phenothiazine-induced dilatation cardiomyopathy: selected aspects of clinical course and morphology].[吩噻嗪所致扩张型心肌病:临床病程及形态学的某些方面]
Klin Med (Mosk). 2009;87(8):13-6.
3
[About secondary phenothiazine-induced cardiomyopathy].[关于继发性吩噻嗪诱发的心肌病]
Klin Med (Mosk). 2011;89(5):30-3.
4
Effects of phenothiazine drugs on serum levels of apolipoproteins and lipoproteins in schizophrenic subjects.
Acta Pharmacol Sin. 2003 Oct;24(10):1001-5.
5
Piperacetazine in ambulatory chronic schizophrenic patients.
Curr Ther Res Clin Exp. 1974 Feb;16(2):124-9.
6
An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.一项使用哌普嗪对慢性精神分裂症患者进行维持治疗的非对照临床研究。
Psychopharmacol Bull. 1977 Jul;13(3):10-1.
7
[Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy].[心肌炎与心肌病:氯氮平治疗引发的被低估的并发症]
Tijdschr Psychiatr. 2010;52(4):223-33.
8
Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy.氯氮平诱发心肌病后成功再次使用氯氮平进行激发试验。
Aust N Z J Psychiatry. 2008 Aug;42(8):747-8.
9
[Somatic pathology and causes of death in schizophrenia].[精神分裂症的躯体病理学及死因]
Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(5):14-9.
10
The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
Psychopharmacol Bull. 1983;19(3):513-7.